Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anti… Meer...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Wei Dai, Books, Health and Well Being, Checkpoint Responses in Cancer Therapy Books>Health and Well Being, Springer-Verlag/Sci-Tech/Trade<
Indigo.ca
new Free shipping on orders above $25. Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug developm… Meer...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. | Checkpoint Responses in Cancer Therapy by Wei Dai Paperback | Indigo Chapters Books > Health > Ailments & Diseases > Cancer P10178, Wei Dai<
Indigo.ca
new in stock. Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.
Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle proc… Meer...
Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book’s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Buch (fremdspr.) Taschenbuch, Springer, 19.11.2010, Springer, 2010<
Thalia.de
Nr. 25603390. Verzendingskosten:, Lieferbar in 1 - 2 Wochen, DE. (EUR 0.00) Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer dru… Meer...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Books > Health > Ailments & Diseases > Cancer List_Books<
Indigo.ca
new in stock. Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.
Paperback, [PU: Humana Press Inc.], Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their … Meer...
Paperback, [PU: Humana Press Inc.], Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs., Oncology<
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anti… Meer...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Wei Dai, Books, Health and Well Being, Checkpoint Responses in Cancer Therapy Books>Health and Well Being, Springer-Verlag/Sci-Tech/Trade<
- new Free shipping on orders above $25. Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug developm… Meer...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. | Checkpoint Responses in Cancer Therapy by Wei Dai Paperback | Indigo Chapters Books > Health > Ailments & Diseases > Cancer P10178, Wei Dai<
new in stock. Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten
Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle proc… Meer...
Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book’s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Buch (fremdspr.) Taschenbuch, Springer, 19.11.2010, Springer, 2010<
Nr. 25603390. Verzendingskosten:, Lieferbar in 1 - 2 Wochen, DE. (EUR 0.00)
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer dru… Meer...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Books > Health > Ailments & Diseases > Cancer List_Books<
new in stock. Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten
Paperback, [PU: Humana Press Inc.], Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their … Meer...
Paperback, [PU: Humana Press Inc.], Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs., Oncology<
1Aangezien sommige platformen geen verzendingsvoorwaarden meedelen en deze kunnen afhangen van het land van levering, de aankoopprijs, het gewicht en de grootte van het artikel, een eventueel lidmaatschap van het platform, een rechtstreekse levering door het platform of via een derde aanbieder (Marktplaats), enz., is het mogelijk dat de door euro-boek.nl meegedeelde verzendingskosten niet overeenstemmen met deze van het aanbiedende platform.
Bibliografische gegevens van het best passende boek
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today's anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book's distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis.
Gedetalleerde informatie over het boek. - Checkpoint Responses in Cancer Therapy by Wei Dai Paperback | Indigo Chapters
EAN (ISBN-13): 9781617378478 ISBN (ISBN-10): 161737847X pocket book Verschijningsjaar: 2010 Uitgever: Wei Dai 328 Bladzijden Gewicht: 0,494 kg Taal: eng/Englisch
Boek bevindt zich in het datenbestand sinds 2012-03-14T22:55:53+01:00 (Amsterdam) Detailpagina laatst gewijzigd op 2022-10-07T19:29:45+02:00 (Amsterdam) ISBN/EAN: 9781617378478
ISBN - alternatieve schrijfwijzen: 1-61737-847-X, 978-1-61737-847-8 alternatieve schrijfwijzen en verwante zoekwoorden: Auteur van het boek: wei Titel van het boek: checkpoint
Gegevens van de uitgever
Auteur: Wei Dai Titel: Cancer Drug Discovery and Development; Checkpoint Responses in Cancer Therapy Uitgeverij: Humana; Humana Press 314 Bladzijden Verschijningsjaar: 2010-11-19 Totowa; NJ; US Gedrukt / Gemaakt in Taal: Engels 213,99 € (DE) 219,99 € (AT) 236,00 CHF (CH) POD XIV, 314 p. 33 illus., 3 illus. in color.
BC; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; DNA; apoptosis; biotechnology; cancer; cancer research; cancer therapy; cell; cell cycle; checkpoint; chemotherapy; development; drug; drug design; drug development; research; Cancer Biology; Pharmacology; Pharmakologie; BB
RB-Pathway.- Targeting the p53/MDM2 Pathway for Cancer Therapy.- DNA Topoisomerases as Targets for the Chemotherapeutic Treatment of Cancer.- Targeting ATM/ATR in the DNA Damage Checkpoint.- Compounds that Abrogate the G2 Checkpoint.- CDK Inhibitors as Anticancer Agents.- CHFR as a Potential Anticancer Target.- Antimicrotubule Agents.- Kinesin Motor Inhibitors as Effective Anticancer Drugs.- Targeting the Spindle Checkpoint in Cancer Chemotherapy.- Antiproliferation Inhibitors Targeting Aurora Kinases.- Plks as Novel Targets for Cancer Drug Design.- Do Histone Deacetylase Inhibitors Target Cell Cycle Checkpoints that Monitor Heterochromatin Structure?. First book to summarize recent advances in identifying components of cell-cycle checkpoints and validating the use of checkpoint proteins as targets for the development of anticancer drugs Distinguished authors write on topics that range from the molecular players affecting DNA synthesis and the response to DNA damage, to advances in the identification of inhibitors for individual mitotic kinases Offers a summary of their findings for researchers in the pharmaceutical and biotechnology industries Valuable resource for cancer researchers studying of cell-cycle regulation, signal transduction, and apoptosis
Andere boeken die eventueel grote overeenkomsten met dit boek kunnen hebben:
